Nanda Kishore Routhu

Assistant Professor

Emory University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Nanda Kishore Routhu is an Assistant Professor at Emory University in the United States. His research focuses on the development and efficacy of vaccines against SARS-CoV-2, including studies on mRNA and modified vaccinia Ankara vaccine platforms. Additionally, he investigates the radioprotective properties of Podophyllum hexandrum and the mechanisms of viral latency in SIV infected cells.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Rama Rao Amara

Emory University

UNITED STATES

View details

Katharine Floyd

Emory University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nanda Kishore Routhu

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates

A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection

A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection

Podophyllum hexandrum and its active constituents: Novel radioprotectants

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs.

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells

Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells

Collaborators (2)

Rama Rao Amara

Katharine Floyd

Make your next move.